DC Circ. Probes Whether FDA Rule Treats Cigar Biz Unfairly
The D.C. Circuit on Friday questioned the U.S. Food and Drug Administration's rationale for a rule under the Tobacco Control Act that cigar makers claim sets an unrealistic timetable for premarket...To view the full article, register now.
Already a subscriber? Click here to view full article